SAN DIEGO, CA--(Marketwired - Jun 10, 2014) - Ivera Medical Corporation, a certified minority-owned business, announced it has filed patent infringement lawsuits against its competitors in federal court in San Diego. U.S. Patent No. 8,740,864, issued by the US Patent and Trademark Office on June 3, 2014, is owned by BD (Becton, Dickinson and Company). It had been previously announced that Ivera Medical has an exclusive license to this patent.
The lawsuits were filed against:
- Catheter Connections (Salt Lake City, UT) for its DualCap Solo and LB IV-Pole Strip products;
- Hospira (Lake Forest, IL) for its Lifeshield EffectIV-Cap product;
- Excelsior Medical (Neptune, NJ) for its SwabCap, SwabFlush, SwabPack, and SwabKit products; and
- Covidien LP and Covidien Sales LLC (Mansfield, MA) for its Kendall Disinfecting Cap products.
"When we pioneered the Port Protector market with Curos®, we secured the rights to this technology, seeing that it would serve as the seminal patent in this space," said Bob Rogers, CEO of Ivera Medical. "With the issuance of this patent, we are looking forward to protecting our significant investment in this market."
About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com
Contact Information:
Contact:
Matt Heindel
Vice President, Business Development
Ivera Medical Corp.
858-752-9514